Austrian biotech company PhagoMed Biopharma GmbH (PhagoMed) successfully completed another financing round. PhagoMed, located at the Vienna Biocenter, is focused on developing virus-(phage-) based therapies against drug-resistant and chronic bacterial infections. Investors provided further €1.5 mill...